Table of Contents Table of Contents
Previous Page  90 / 172 Next Page
Information
Show Menu
Previous Page 90 / 172 Next Page
Page Background

Abstracts of the 22

nd

National Congress of Digestive Diseases / Digestive and Liver Disease 48S2 (2016) e67–e231

e151

Background and aim:

Neuroendocrine neoplasms (NENs) are

a heterogeneous group of neoplasms, which differ in biologic

behavior, histologic features and response to treatment.

The behavior and therapeutic options of NENs depend on the

location of the primary tumors.

NENs with unknown primary site (NENs-UP) account for 10 to 13

percent of all NENs.

Aim:

To describe clinical and histological findings and the diagnostic

work-up of patients with histologically proven metastatic NENs of

unknown primary.

Material and methods:

Study period: Between January 2005 to

January 2015, 93 patients with metastatic gastrointestinal NENs

were referred to our Institution.

Patients:

Among 93 patients, 17 (18%) presented with immuno­

histochemically proven neuroendocrine metastases, without

evidence of primary site.

Of these, 11 were male and six female. The median age at the

diagnosis was 64 years (range 33-74). In all the cases, an exhaustive

work-up based on computed tomography (CT), magnetic resonance

(MRI) and somatostatin receptor scintigraphy (SRS) )/ Gallium-68

PET was performed.

Results:

14 of the 17 patients with NENs-UP (82%), showed

hepatic metastases, whereas in three patients an abdominal nodal

involvement was detected.

In 14 of the 17 cases (82%), liver or nodal metastases were firstly

diagnosed by abdominal ultrasound, performed during surveillance

of chronic diseases in six patients and for gastrointestinal symptoms

in eight.

16 of the 17 tumors (88%) were well differentiated (G1 in five cases

and G2 in 11), with a poorly differentiated carcinoma in one patient.

Hormonal syndrome was diagnosed in 11 cases (65%). In particular

carcinoid syndrome was present in 8 patients, Zollinger-Ellison

syndrome in two and Verner-Morrison syndrome in one.

In the course of a strict work-up, the primary tumor was diagnosed

in 12 cases (71%), after a median of 8.5 months (range 3-120), of

these eight (67%) had a functioning form.

The primary site was identified as pancreas by a repeated abdominal

CT (#3); terminal ileum (#2) and colon (#1) by colonoscopy;

central ileum by double balloon enteroscopy (#1) and pancreas by

endoscopic ultrasound (EUS) (#1).

Again, laparoscopy identified a jejunal, ileal, Meckel’s diverticulum

and pancreatic primary tumor in further four patients.

In our series, five cases are still classified as NENs-UP.

Conclusions:

Despite the continuous advances in diagnostic

techniques, including radiologic, endoscopic and immunohisto­

chemical methods, metastatic NENs still represent a clinical

challenge, involving multidisciplinary expertise.

In the present series, NENs remain of unknown primary origin in

a relevant proportion of cases (5/93, 5.3%), even after an in-depth

work-up. Data from our series suggest that NENs-UP may derive

more frequently from the gastrointestinal tract. The presence of

hormone-related symptoms may help to better localize the primary

site.

P.05.10

DUODENAL NEUROENDOCRINE TUMORS – DATA FROM A SINGLE

CENTRE

Rossi R.E.*, Cavalcoli F., Conte D., Massironi S.

Department of Gastroenterology and Endoscopy, Fondazione IRCCS

Ca’ Granda, Ospedale Maggiore Policlinico, and Department of

Pathophysiology and Organ Transplantation, Università degli Studi di

Milano, milano, Italy

Background and aim:

Duodenal neuroendocrine neoplasms

(D-NENs) are heterogeneous tumors, previously classified as foregut

NET, whose prognosis can be good as for gastric neuroendocrine

tumors or bad when facing with more aggressive forms. Their

optimal management remains to be clarified, even if endoscopic

resection is increasingly performed instead of surgery. Present

series was aimed at reporting a single-centre experience.

Material and methods:

Retrospective analysis of patients with

histologically confirmed diagnosis of D-NENs managed at our

Institution.

Results:

From 2004 to 2014, 12 patients (9 M and 3 F, median

age of 67 years, range 26-79) were diagnosed and treated. The

D-NEN was single in all but one patient who was diagnosed with

MEN1 syndrome and had both a D-NEN and multiple pancreatic

NENs. Two patients had a peri-ampullary D-NEN. The median

diameter was 20 mm (range 5-37). A non-functioning D-NEN was

incidentally diagnosed in seven cases, a gastrinoma in three and

a somatostatinoma in two cases, respectively. According to 2010

WHO classification, D-NEN was G2 in three cases and G1 in nine.

At enrollement, four patients (33%) had metastases, to lymph nodes

(#2), liver (#1) and both (#1). D-NEN was removed in 10 cases

(83%), endoscopically (#3) or surgically (#7). An elder patient, with

8 mm non metastatic gastrinoma unsuitable for surgery, was only

followed-up. One patient was lost at follow-up. Over a median

follow-up of 33 months (range 2-133), two patients died of the

disease (metastatic somatostatinoma and gastrinoma, repectively,

both progressive after surgery and not responsive to somatostatin

analog, chemotherapy and peptide receptor radionuclide therapy

treatments).

Conclusions:

D-NENs may be metastatic at the diagnosis in up to 33%

of the cases, thus nuclear imaging should be performed to exclude

distant metastases. Endoscopy and surgery play a primary role in

the management of the disease. Prognosis may be highly variable.

Further studies are needed to better define standardised dedicated

guidelines for D-NENs, including the optimal management and the

perfect follow-up intervals.

P.05.11

UNUSUAL ONSET OF COLONIC SARCOIDOSIS: A CASE REPORT

Vigliardi G.*, Pastena F., Erra P.

U.O.C. Chirurgia Generale Ospedale “F.Veneziale”, Isernia, Italy

Background and aim:

Sarcoidosis is a multisystem chronic

inflammatory condition of unknown etiology that has the potential

to involve every tissue in the body. Sarcoidosis in the gastrointestinal

system, and particularly the colon, is very rare.

Material and methods:

We report a case of a 57-year-old man in

apparent good health who presented with newly onset abdominal

pain and symptoms related to colonic obstruction. The patient

was healthy until three to four weeks prior to presentation, when

new-onset constipation developed and he began passing pencil-

like stools. A physical examination of the patient revealed mild

abdominal distention and tenderness of the right lower abdominal

quadrant. Routine hematology and biochemistry analyses were

normal; Carcinoembryonic antigen levels were slightly elevated (3.6

ng/mL). A colonoscopy revealed a stenotic obstructive lesion at the

cecum-ascending colon transition and we were unable to advance

the colonoscope beyond this area. Biopsy specimens obtained from

this site showed no evidence of a neoplastic lesion, but rather an

acute inflammatory infiltration of the submucosa. An abdominal CT

revealedmarked symmetric concentricwall thickening in the cecum-

ascending colon, which notably reduced the enteral lumen and was

associated with a heterogeneous hyperdensity of perivisceral fat

tissue and multiple satellite lymphadenopathies along the ileocolic

vessels. A malignant colonic lesion was suspected, despite the

unclear histology results. The patient underwent an exploratory

laparotomy.